Matches in Wikidata for { <http://www.wikidata.org/entity/Q60657422> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q60657422 description "2015 թվականի դեկտեմբերի 10-ին հրատարակված գիտական հոդված" @default.
- Q60657422 description "article scientifique publié en 2015" @default.
- Q60657422 description "artículu científicu espublizáu n'avientu de 2015" @default.
- Q60657422 description "im Januar 2016 veröffentlichter wissenschaftlicher Artikel" @default.
- Q60657422 description "scientific article published on 10 December 2015" @default.
- Q60657422 description "wetenschappelijk artikel" @default.
- Q60657422 description "наукова стаття, опублікована в січні 2016" @default.
- Q60657422 name "Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition" @default.
- Q60657422 name "Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition" @default.
- Q60657422 type Item @default.
- Q60657422 label "Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition" @default.
- Q60657422 label "Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition" @default.
- Q60657422 prefLabel "Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition" @default.
- Q60657422 prefLabel "Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition" @default.
- Q60657422 P1433 Q60657422-ACC3460F-FF7C-4705-A631-CA4BAC8C1CFA @default.
- Q60657422 P1476 Q60657422-DCB26362-98AD-4FE9-8822-3D6FDF5954A7 @default.
- Q60657422 P2093 Q60657422-0F93C42B-95C9-4884-9569-3F207CAEFB75 @default.
- Q60657422 P2093 Q60657422-349235B6-C903-46F9-9747-757CF81DF96E @default.
- Q60657422 P2093 Q60657422-36C7D8BD-3864-4F4E-A0F3-92BA6ED86351 @default.
- Q60657422 P2093 Q60657422-572DB71A-7E7D-4ED9-9F30-C0E6441067D5 @default.
- Q60657422 P2093 Q60657422-61C1E42D-4DCB-4B2F-89A8-7A02F2E80998 @default.
- Q60657422 P2093 Q60657422-6466980A-3573-4284-9610-7874B5A5FEA0 @default.
- Q60657422 P2093 Q60657422-69C48672-DAC9-47B1-90DD-60D12DE0C6C3 @default.
- Q60657422 P2093 Q60657422-974FF905-B7B1-42E5-89A6-307114DCB1EE @default.
- Q60657422 P2093 Q60657422-97BF07CD-F8B0-46B3-A313-02A857DC224C @default.
- Q60657422 P2093 Q60657422-983CA2FB-5C73-49EF-939D-E3D55C9C7BD4 @default.
- Q60657422 P2093 Q60657422-A35FB5D9-F1A3-48F9-A64D-84DFA800BCFD @default.
- Q60657422 P2093 Q60657422-E0019AF3-E042-4644-946E-CFC436D0D0F2 @default.
- Q60657422 P2093 Q60657422-EDE3D556-9EED-4D7E-BDD3-6751CABCD8AA @default.
- Q60657422 P304 Q60657422-25AEB115-8D48-4BE5-B4EC-991558BC5734 @default.
- Q60657422 P31 Q60657422-A07F4DC4-2A84-4711-BF13-560C820CCB3C @default.
- Q60657422 P356 Q60657422-06B6770F-30FD-48A7-B5A0-88B2DC889785 @default.
- Q60657422 P478 Q60657422-4719D26D-A1AD-4206-909D-EE30A7112916 @default.
- Q60657422 P50 Q60657422-4EAA12F9-44D2-40F6-A9D6-6C61B41771C0 @default.
- Q60657422 P50 Q60657422-D4B1A910-9245-4C4C-AA75-F29D8AD26E2E @default.
- Q60657422 P50 Q60657422-E72EEE9E-92A2-4202-9A37-3E79EBBE0852 @default.
- Q60657422 P50 Q60657422-F7B28174-2DEB-4CD8-A90E-7DA131D65F40 @default.
- Q60657422 P577 Q60657422-9C8586BD-50CF-4146-B787-8428FF0DBC8F @default.
- Q60657422 P698 Q60657422-35998D45-CECB-49D6-B52E-E9F100A3A7E2 @default.
- Q60657422 P921 Q60657422-3AEC3959-24C3-44A0-96B6-38D07A1F1C32 @default.
- Q60657422 P921 Q60657422-7E005107-2BCE-49CB-BCA4-572409435998 @default.
- Q60657422 P921 Q60657422-9959c322-68c1-4dbf-aa6b-b1defac4ca32 @default.
- Q60657422 P921 Q60657422-ED161AAB-C931-4582-9A24-F6A77ACA66CA @default.
- Q60657422 P356 J.EJMECH.2015.12.004 @default.
- Q60657422 P698 26708111 @default.
- Q60657422 P1433 Q3008624 @default.
- Q60657422 P1476 "Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition" @default.
- Q60657422 P2093 "Aikaterini S Chajistamatiou" @default.
- Q60657422 P2093 "Bálint Kónya" @default.
- Q60657422 P2093 "Cédric Duret" @default.
- Q60657422 P2093 "Didier Tousch" @default.
- Q60657422 P2093 "Jacqueline Azay-Milhau" @default.
- Q60657422 P2093 "Jean-Pierre Praly" @default.
- Q60657422 P2093 "Jérémy Leroy" @default.
- Q60657422 P2093 "Michel Tournier" @default.
- Q60657422 P2093 "Patrick Maurel" @default.
- Q60657422 P2093 "Pierre Petit" @default.
- Q60657422 P2093 "Pál Gergely" @default.
- Q60657422 P2093 "Sophie Balzarin" @default.
- Q60657422 P2093 "Sébastien Vidal" @default.
- Q60657422 P304 "444-454" @default.
- Q60657422 P31 Q13442814 @default.
- Q60657422 P356 "10.1016/J.EJMECH.2015.12.004" @default.
- Q60657422 P478 "108" @default.
- Q60657422 P50 Q118869494 @default.
- Q60657422 P50 Q43183492 @default.
- Q60657422 P50 Q57053496 @default.
- Q60657422 P50 Q85394883 @default.
- Q60657422 P577 "2015-12-10T00:00:00Z" @default.
- Q60657422 P698 "26708111" @default.
- Q60657422 P921 Q1418791 @default.
- Q60657422 P921 Q271993 @default.
- Q60657422 P921 Q3025883 @default.
- Q60657422 P921 Q37525 @default.